Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2

被引:41
作者
Vokurka, S. [1 ]
Steinerova, K. [1 ]
Karas, M. [1 ]
Koza, V. [1 ]
机构
[1] Univ Hosp Plzen Pilsen, Dept Haematooncol, Plzen 30460, Pilsen, Czech Republic
关键词
oral mucositis; melphalan; stem cell transplantation; toxicity; graft-versus-host disease; VERSUS-HOST-DISEASE; HIGH-DOSE MELPHALAN; MARROW-TRANSPLANTATION; CHEMOTHERAPY; FLUDARABINE; PREVENTION; RECIPIENTS; THERAPY; MYELOMA;
D O I
10.1038/bmt.2009.66
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The fludarabine ( FLU)/melphalan (MEL) conditioning regimen containing FLU and high-dose MEL was analyzed in comparison with the BU/CY2 regimen to characterize oral mucositis ( OM) and risk factors. OM incidence significantly varied between BU/CY2 and FLU/ MEL ( 100 vs 78%, P = 0.004), but the incidence of severe OM grades 3-4 WHO and kinetics of OM were fully comparable. Patients with OM persisting on day +21 had more acute GVHD (68 vs 32%, P = 0.005), which tended to occur earlier than among those without such prolonged OM. Multivariate analysis showed significant dependency of acute GVHD on severity and prolonged duration of OM and significant correlation between OM severity and its prolonged duration. Body surface area-based dosing in the FLU/ MEL regimen led to a wide range of MEL doses administered per kilogram body weight (2.5-5.2 mg/kg, median 3.5). In multivariate analysis, MEL dose per kilogram of body weight was found to be a significant predictor of OM incidence and severity. Female gender and lower body mass index were less important variables than the fact that the actual dose of MEL administered per kilogram of body weight was relatively high when the dosage was calculated on the basis of body surface area. Bone Marrow Transplantation ( 2009) 44, 601-605; doi: 10.1038/bmt.2009.66; published online 6 April 2009
引用
收藏
页码:601 / 605
页数:5
相关论文
共 27 条
[1]   Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients [J].
Aisa, Y ;
Mori, T ;
Kudo, M ;
Yashima, T ;
Kondo, S ;
Yokoyama, A ;
Ikeda, Y ;
Okamoto, S .
SUPPORTIVE CARE IN CANCER, 2005, 13 (04) :266-269
[2]   Fludarabine-meiphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated MD Anderson Cancer Center experience [J].
Anderlini, Paolo ;
Saliba, Rima ;
Acholonu, Sandra ;
Giralt, Sergio A. ;
Andersson, Borje ;
Ueno, Naoto T. ;
Hosing, Chitra ;
Khouri, Issa F. ;
Couriel, Daniel ;
de Lima, Marcos ;
Qazilbash, Muzaffar H. ;
Pro, Barbara ;
Romaguera, Jorge ;
Fayad, Luis ;
Hagemeister, Frederick ;
Younes, Anas ;
Munsell, Mark F. ;
Champlin, Richard E. .
HAEMATOLOGICA, 2008, 93 (02) :257-264
[3]  
[Anonymous], 2008, J NATL COMPRE CANC N, DOI DOI 10.6004/JNCCN.2008.0001
[4]   Prospective Oral Mucositis Audit: Oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European blood and marrow transplantation mucositis advisory group [J].
Blijlevens, Nicole ;
Schwenkglenks, Matthias ;
Bacon, Pamela ;
D'Addio, Alessandra ;
Einsele, Hermann ;
Maertens, Johan ;
Niederwieser, Dietger ;
Rabitsch, Werner ;
Roosaar, Ann ;
Ruutu, Tapani ;
Schouten, Harry ;
Stone, Rebecca ;
Vokurka, Samuel ;
Quinn, Barry ;
McCann, Shaun .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) :1519-1525
[5]   A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation [J].
Bolwell, B ;
Sobecks, R ;
Pohlman, B ;
Andresen, S ;
Rybicki, L ;
Kuczkowski, E ;
Kalaycio, M .
BONE MARROW TRANSPLANTATION, 2004, 34 (07) :621-625
[6]   A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation [J].
Bolwell, BJ ;
Kalaycio, M ;
Sobecks, R ;
Andresen, S ;
Kuczkowski, E ;
Bernhard, L ;
Lomax, R ;
Kohuth, J ;
Mendiola, S ;
Rybicki, L ;
Pohlman, B .
BONE MARROW TRANSPLANTATION, 2002, 30 (09) :587-591
[7]   Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy - Induced mucositis and neutropenia [J].
Branda, RF ;
Naud, SJ ;
Brooks, EM ;
Chen, Z ;
Muss, H .
CANCER, 2004, 101 (05) :1058-1064
[8]   Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma [J].
Chansky, K ;
Benedetti, J ;
Macdonald, JS .
CANCER, 2005, 103 (06) :1165-1171
[9]   Oral mucositis incidence and severity after methotrexate and non-methotrexate containing GVHD prophylaxis regimens [J].
Cutler, C ;
Li, SL ;
Kim, HT ;
Laglenne, P ;
Ford, C ;
Ho, V ;
Lee, SJ ;
Alyea, E ;
Soiffer, R ;
Antin, JH ;
Sonis, S .
BLOOD, 2004, 104 (11) :104A-104A
[10]  
DEVERGIE A, 2008, 2008 REVISED EDITION, P219